The Study of Internet-delivered, Transdiagnostic Treatments for Anxiety and Depression

NAActive, not recruitingINTERVENTIONAL
Enrollment

2,400

Participants

Timeline

Start Date

August 25, 2021

Primary Completion Date

October 1, 2024

Study Completion Date

January 1, 2025

Conditions
Anxiety DisordersDepression
Interventions
BEHAVIORAL

Treatment condition: Internet-administered Unified protocol

"Treatment condition:~The cognitive, behavioral treatment Unified protocol is a transdiagnostic treatment for anxiety and depression. Participants are taught five techniques in order to find new and more helpful ways to react to hindering thoughts and feelings: mindfulness, cognitive flexibility, identify and reduce behavioral avoidance, increase willingness to experience physiological sensations and exposure. The intervention is delivered online through a secure platform. Modules consist of text and the participants can work with the material whenever they wish to. Participants gain access to a new treatment modul every week."

BEHAVIORAL

Treatment condition: Internet-administered Affect phobia treatment

The aim of psychodynamic Affect phobia treatment is for the patient to reach an intellectual and emotional understanding of his/hers problems. The goal of the treatment is for participants to decrease emotional avoidance and start to approach emotions and increase emotional awareness. Participants are taught this through linking their symptoms to their emotional avoidance, observe frequent and maladaptive patterns in relationships and see how these are linked to emotional avoidance. The intervention is delivered online through a secure platform. Modules consist of text and the participants can work with the material whenever they wish to. Participants gain access to a new treatment modul every week.

OTHER

Treatment condition: Waitlist control

The waitlist condition is a control condition without any intervention.

OTHER

Treatment length: 8 weeks

Participants will partake in their treatment condition for 8 weeks.

OTHER

Treatment length: 16 weeks

Participants will partake in their treatment condition for 16 weeks.

OTHER

Access to a moderated forum

During their treatment, participants will have access to a discussion forum moderated by a clinician. Participants are encouraged to discuss questions and experiences related to their treatment condition.

OTHER

No access to a moderated forum

Participants will not have access to a moderated forum, hence their treatment is self-guided.

Trial Locations (1)

10691

Department of Psychology, Stockholm

All Listed Sponsors
lead

Stockholm University

OTHER